Shares of Walgreen Boots Alliance and Rite Aid are trading lower after the merger of the two drugstore companies is facing US antitrust concerns. » Read More
By: Rachel Cao
The Apple chip provider reported first quarter earnings of $1.61 per share on revenues of $914 million. » Read More
By: Bob Pisani
Trump offered precious little about the issues that would matter most to earnings: tax cuts and infrastructure spending. » Read More
TipRanks presents the top 10 stock ideas for next year from the five best-performing tech analysts of 2016.
"Remember, there's always the wise guys who say, 'Now it's on the front page, so I've got to sell it,'" Cramer says.
Fred's Pharmacy said it signed an agreement with Walgreens and Rite Aid to purchase stores and certain assets for $950 million in cash.
Homebuilding stocks are rallying, but is the surge almost over?
The market in secondary trading in shares of hot startups has made a strong comeback.
Goldman Sachs says its "High Sharpe Ratio" strategy beat the S&P 500 by 7 percentage points per year since 1999.
Jim Cramer clarifies why it's not time to sell Chinese stocks as the rhetoric between Donald Trump and China heats up.
Jim Cramer says U.S. companies that do business in China may need to sacrifice earnings under Trump.
The only expected major news event is Bank of Japan's monetary policy meeting, scheduled to conclude ahead of Tuesday's U.S. trading session.
The "Fast Money" traders look at different housing and homebuilding stocks that they think are building up for a strong 2017.
Jim Cramer chronicles the stunning decline in department stores and what it means for the future.
Jim Cramer expects analyst upgrades to potentially drive the market until the end of the year.
Conventional wisdom is the market rally may lose steam in the beginning of 2017, but that consensus could be wrong, one expert says.
The postelection inflow is one and half times that of all 2015, David Santschi, chief executive officer at TrimTabs, said in a release.
These are the stocks posting the largest moves after the bell on Monday: Biogen, Walt Disney Company and more.
One technician is betting that Nike will continue to disappoint following its earnings report this week.
Get the best of CNBC in your inbox